Ken Griffin Citadel Advisors
Ken Griffin founded Citadel, one of the world’s largest and most successful hedge funds. Starting his trading career from his Harvard dorm room at a young age, Griffin quickly developed a keen sense for markets and built Citadel into a global powerhouse with billions in assets under management. Known for his quantitative and technology-driven strategies, Griffin has also made headlines for significant philanthropic contributions, supporting causes in education, the arts, and public institutions. Over the years, he has earned recognition as one of the preeminent figures in modern finance.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
ATVI
Activision Blizzard
ATVI
|
+$980M |
| 2 |
Humana
HUM
|
+$637M |
| 3 |
Apple
AAPL
|
+$620M |
| 4 |
Home Depot
HD
|
+$541M |
| 5 |
Microsoft
MSFT
|
+$539M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Invesco QQQ Trust
QQQ
|
+$770M |
| 2 |
McDonald's
MCD
|
+$654M |
| 3 |
Cigna
CI
|
+$498M |
| 4 |
Digital Realty Trust
DLR
|
+$430M |
| 5 |
Amazon
AMZN
|
+$429M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 3.91% |
| 2 | Healthcare | 3.33% |
| 3 | Consumer Discretionary | 2% |
| 4 | Industrials | 1.79% |
| 5 | Financials | 1.73% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
6551
First Trust Active Factor Large Cap ETF
AFLG
$746M
| $957K | ﹤0.01% |
38,754
+1,664
| +4% | +$42.4K |
|
|
SAND
6552
PUT
DELISTED
Sandstorm Gold
SAND
| $957K | ﹤0.01% |
205,300
-500
| -0.2% | -$2.63K |
|
6553
PUT
Elanco Animal Health
ELAN
$11.8B
| $957K | ﹤0.01% |
85,100
-158,600
| -65% | -$1.84M |
|
6554
Invesco S&P SmallCap Health Care ETF
PSCH
$184M
| $956K | ﹤0.01% |
25,462
+5,500
| +28% | +$229K |
|
6555
PUT
Portillo's
PTLO
$356M
| $956K | ﹤0.01% |
62,100
-54,900
| -47% | -$1.07M |
|
6556
Synaptics
SYNA
$4.01B
| $955K | ﹤0.01% |
10,676
-5,659
| -35% | -$497K |
|
6557
Hovnanian Enterprises
HOV
$738M
| $955K | ﹤0.01% |
9,392
-15,077
| -62% | -$1.58M |
|
6558
Innovator US Equity Power Buffer ETF February
PFEB
$926M
| $955K | ﹤0.01% |
+31,347
| New | +$970K |
|
6559
CALL
Dine Brands
DIN
$449M
| $954K | ﹤0.01% |
19,300
+3,600
| +23% | +$201K |
|
6560
PUT
iShares Global Tech ETF
IXN
$9.22B
| $954K | ﹤0.01% |
16,500
+13,900
| +535% | +$845K |
|
6561
CALL
TaskUs
TASK
$666M
| $954K | ﹤0.01% |
91,900
-19,500
| -18% | -$210K |
|
|
NZUS
6562
DELISTED
State Street SPDR MSCI USA Climate Paris Aligned ETF
NZUS
| $953K | ﹤0.01% |
39,672
+30,166
| +317% | +$758K |
|
6563
CALL
JPMorgan Nasdaq Equity Premium Income ETF
JEPQ
$41.5B
| $953K | ﹤0.01% |
20,300
+13,300
| +190% | +$641K |
|
6564
PUT
SPX Corp
SPXC
$10.5B
| $952K | ﹤0.01% |
11,700
+9,600
| +457% | +$773K |
|
|
MRNS
6565
CALL
DELISTED
Marinus Pharmaceuticals, Inc
MRNS
| $952K | ﹤0.01% |
118,300
+61,200
| +107% | +$509K |
|
6566
PUT
Tandem Diabetes Care
TNDM
$1.61B
| $951K | ﹤0.01% |
45,800
+6,900
| +18% | +$190K |
|
6567
PUT
LCI Industries
LCII
$2.56B
| $951K | ﹤0.01% |
8,100
| – | – |
|
6568
PUT
Cognex
CGNX
$10.6B
| $951K | ﹤0.01% |
22,400
+6,400
| +40% | +$315K |
|
6569
Aemetis
AMTX
$136M
| $950K | ﹤0.01% |
229,036
+131,427
| +135% | +$804K |
|
6570
Rallybio
RLYB
$90M
| $950K | ﹤0.01% |
35,245
-1,676
| -5% | -$72.6K |
|
6571
CALL
iShares S&P GSCI Commodity-Indexed Trust
GSG
$960M
| $950K | ﹤0.01% |
42,200
+2,600
| +7% | +$55.8K |
|
6572
PUT
Cabot Corp
CBT
$4.41B
| $949K | ﹤0.01% |
13,700
+2,100
| +18% | +$146K |
|
|
HKND
6573
DELISTED
Humankind US Stock ETF
HKND
| $949K | ﹤0.01% |
35,153
+1,917
| +6% | +$54K |
|
6574
CALL
Global X Russell 2000 Covered Call ETF
RYLD
$1.4B
| $949K | ﹤0.01% |
55,600
+36,100
| +185% | +$640K |
|
6575
CALL
Schwab U.S Small- Cap ETF
SCHA
$23.3B
| $949K | ﹤0.01% |
45,800
-7,200
| -14% | -$158K |
|
Similar funds
Ken Griffin's Q3 2023 Portfolio in Review
As of Q3 2023, Ken Griffin held 15,669 positions worth $467B, down 3.6% from $484B the previous quarter. Its ten largest holdings account for 33% of the portfolio.
Ken Griffin's Q3 2023 filing shows 1,406 new, 6,433 increased, 6,116 reduced and 1,460 closed positions. Its largest new stake was Arm: 3,445,206 shares worth $184M. The largest sale was Invesco QQQ Trust, an estimated $770M.
By sector, the portfolio is most concentrated in Technology at 3.9% of assets, up from 3% a quarter earlier, followed by Healthcare and Consumer Discretionary.
- Ken Griffin's largest Q3 2023 buy was Arm: 3,445,206 shares worth $184M.
- Ken Griffin added most to Activision Blizzard in Q3 2023, an estimated $980M increase.
- Ken Griffin's biggest Q3 2023 reduction was Invesco QQQ Trust, cutting an estimated $770M.
- Ken Griffin fully exited Coca-Cola Europacific Partners in Q3 2023, selling an estimated $124M.
- Ken Griffin's ten largest holdings make up 33% of its $467B portfolio in Q3 2023.
- Ken Griffin opened 1,406 new positions and closed 1,460 in Q3 2023.
- Ken Griffin's portfolio value fell 3.6% quarter-over-quarter to $467B.
Based on Citadel Advisors's 13F filing for Q3 2023, filed 14 Nov 2023.